| Firm |
|
Analyst |
BMO Capital Markets
3 Times Square
New York, NY 10036
T. 212-885-4091
www.bmocm.com |
|
Robert Hazlett |
|
Credit Suisse
11 Madison Avenue
New York, NY 10010-3629
T. 212-325-3297
www.credit-suisse.com |
|
Scott Hirsch |
|
Neponset Equity Research
62 Maple Street, Suite 2
Boston, MA 02136
T. 615-279-0738
|
|
Noelle Tune |
|
Pacific Growth Equities
One Bush Street, Suite 1700
San Francisco, CA 94104
T. 415-263-6646
www.pacificgrowth.com |
|
Patricia L. Bank |
|
Roth Capital Partners
24 Corporate Plaza
Newport Beach, CA 92660
T. 949-720-7162
www.rothcp.com |
|
Greg Gust |
|
Susquehanna International Group
40 Wall Street, 4th Floor
New York, NY 10005
T. 212-709-5374
www.susq.com |
|
Angela Larson |
|
Thomas Weisel Partners
Pacific Telesis Tower
One Montgomery St. #3700
San Francisco, CA 94104
T. 415-364-7038
www.tweisel.com |
|
Donald B. Ellis, Pharm. D. |
|
Wachovia Securities
375 Park Avenue
New York, NY 10152
T. 212-214-0000
www.wachoviasec.com |
|
Michael K. Tong |
|
Salix Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Salix Pharmaceuticals' performance
made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of the Company or its management. Salix Pharmaceuticals does not by its reference above or distribution
imply its endorsement of or concurrence with such information, conclusions or recommendations.